FDA Approves First Generic Advair Diskus
January 30, 2019 -- The U.S. Food and Drug Administration today approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in patients aged four years and older and...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Advair | Advair Diskus | Asthma | Flonase | Flovent | Food and Drug Administration (FDA) | Pharmaceuticals